Lilly

Finance

Stocks making the biggest moves midday: Eli Lilly, Hasbro, Philip Morris, Intel, Micron &

These are the stocks posting the largest moves in midday trading. This article was originally published by a Cnbc.com. Read

Read More
Business

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep

Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive

Read More
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.

Read More
Earnings

We’re raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat

Eli Lilly ‘s fourth-quarter results blew past Wall Street estimates on Wednesday, as key GLP-1 drugs, Mounjaro for diabetes and

Read More
Earnings

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro

Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its

Read More
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for

Read More
Business

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation

Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik Tavitian |

Read More
Business

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov.

Read More
Business

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer

U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in

Read More
Business

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight

Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on

Read More

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.